T1078 The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology

[1]  M. Fujishiro,et al.  LONG‐TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE‐AGED JAPANESE POPULATION , 2009, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[2]  M. Burkitt,et al.  Importance of gastrin in the pathogenesis and treatment of gastric tumors. , 2009, World journal of gastroenterology.

[3]  F. Di Mario,et al.  Non-invasive tests in gastric diseases. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[4]  K. Chayama,et al.  Evaluation of Gastric Cancer Risk Using Topography of Histological Gastritis: A Large-scaled Cross-sectional Study , 2008, Digestive Diseases and Sciences.

[5]  A. Amirzargar,et al.  Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  H. Brenner,et al.  Epidemiology of chronic atrophic gastritis: population‐based study among 9444 older adults from Germany , 2007, Alimentary pharmacology & therapeutics.

[7]  H. Brenner,et al.  Prevalence of Chronic Atrophic Gastritis in Different Parts of the World , 2006, Cancer Epidemiology Biomarkers & Prevention.

[8]  D. Graham,et al.  Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  G. Cavestro,et al.  Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[10]  M. Rugge,et al.  Serological Markers for Gastric Atrophy in Asymptomatic Patients Infected with Helicobacter pylori , 2004, American Journal of Gastroenterology.

[11]  A. Costa-Pereira,et al.  Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening , 2004, Journal of medical screening.

[12]  P. Correa,et al.  Complications of an Addisonian crisis , 2004, Gut.

[13]  M. Rasmussen,et al.  Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study , 2003, European journal of gastroenterology & hepatology.

[14]  F. Mégraud,et al.  Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics , 2003, British Journal of Cancer.

[15]  K. Miki.  Gastric cancer screening using the serum pepsinogen test method , 2002, Gastric Cancer.

[16]  Chien-Jen Chen,et al.  Cancer epidemiology and control in Taiwan: a brief review. , 2002, Japanese journal of clinical oncology.

[17]  P. Sipponen,et al.  Atrophic Gastritis Serum Levels of Amidated Gastrin-17 and Pepsinogen I in Atrophic Gastritis: An Observational Case-Control Study , 2002, Scandinavian journal of gastroenterology.

[18]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[19]  R. V. D. van der Hulst,et al.  Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. , 1999, Journal of clinical pathology.

[20]  Stolte,et al.  Observer agreement on the grading of gastric atrophy , 1999, Histopathology.

[21]  D. Forman,et al.  Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. , 1996, British Journal of Cancer.

[22]  T. Kawamoto,et al.  Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens , 1995, Japanese journal of cancer research : Gann.

[23]  K. Ishikawa,et al.  Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer , 1993, Japanese journal of cancer research : Gann.

[24]  T. Ledin,et al.  The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. , 1989, Scandinavian journal of gastroenterology.

[25]  P. Correa.  Chronic gastritis: a clinico-pathological classification. , 1988, The American journal of gastroenterology.

[26]  Kenji Takahashi,et al.  Serum pepsinogens as a screening test of extensive chronic gastritis , 1987, Gastroenterologia Japonica.

[27]  J. Haapakoski,et al.  Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross‐sectional data , 1985, International journal of cancer.

[28]  T. Wang,et al.  The gastrins: their production and biological activities. , 2001, Annual review of physiology.

[29]  R. M. Huberman,et al.  Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. , 1996, Human pathology.